ClinicalTrials.Veeva

Menu

Radiofrequency-Based Debridement vs. Mechanical Debridement for the Treatment of Articular Cartilage Lesions

C

Christopher Kaeding

Status

Terminated

Conditions

Articular Cartilage Disorder of Knee

Treatments

Device: Mechanical Debridement
Device: Radiofrequency-Based Debridement

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT03678948
2018H0244

Details and patient eligibility

About

The purpose of this study is to evaluate the changes in clinical and imaging outcomes following arthroscopic treatment of chondral lesion(s) by Radiofrequency-Based debridement or Mechanical Debridement in subjects 18-50 years of age.

Full description

This is a non-inferiority, prospective, single blinded, randomized, single-center study design with enrollment of 82 randomized subjects (to assure 70 subjects complete the study). The sample size of 82 participants was calculated from a power analysis. The study was powered to detect at least a seven point change in KOOS pain score based on achieving 80% statistical power to detect a non-inferiority margin. Study duration will be until the last subject enrolled reaches 52 weeks post-operative.

The 82 randomized subjects will be randomized at a 1:1 ratio into the Werewolf Coblation wand treatment group or mechanical debridement treatment group. Subjects will be blinded to their treatment assignment until they complete all study visits. Upon withdraw from the study, termination from the study, or new or recurrent symptoms requiring a subsequent arthroscopy, the blinded assignment will be revealed to the subject.

Enrollment

6 patients

Sex

All

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Given written informed consent on the IRB approved consent form specific to the study, prior to study participation

  • 18-50 years old

  • Male or Female

  • Suspected chondral damage in the following locations where debridement is indicated:

    • Medial femoral condyle
    • Lateral femoral condyle
    • Trochlea
    • Patella
  • < 30% joint space narrowing as seen on x-ray (merchant view, AP and PA Rosenberg)

  • 1 or more chondral lesion(s) as noted on MRI

Exclusion criteria

  • Previous chondral treatment in the same compartment (prior debridement and lavage performed more than three months prior to baseline are acceptable)

  • Focal chondral defect indicated for concomitant procedures (i.e., microfracture, ACI, MACI, OATs)

  • Concomitant procedures that are not allowed:

    • Lateral retinacular release
    • Excision of osteophytes
    • Subchondroplasty
    • Manipulation under anesthesia
    • ACL reconstruction
    • Quad tendon repair
    • Patellar tendon repair
    • Patellar tendon debridement
    • Multiligament reconstruction
  • Pregnant and/or intending to become pregnant during this study period

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

6 participants in 2 patient groups

Radiofrequency-Based Debridement
Active Comparator group
Description:
The Smith and Nephew WEREWOLF COBLATION System is indicated for all soft tissue types in the knee. The WEREWOLF COBLATION System is a FDA cleared bipolar, radiofrequency electrosurgical system designed for use in orthopaedic/arthroscopic surgical procedures.
Treatment:
Device: Radiofrequency-Based Debridement
Mechanical Debridement
Active Comparator group
Treatment:
Device: Mechanical Debridement

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems